cbdMD (YCBD) Shares Outstanding (Diluted Average) (2018 - 2025)

cbdMD's (YCBD) quarterly Shares Outstanding (Diluted Average) came in at $4.0 million in Q3 2025, up 646.22% year-on-year from $539069.0 in Q3 2024, and up 646.22% quarter-over-quarter from $539069.0 in Q3 2024.

cbdMD (YCBD) Shares Outstanding (Diluted Average) (2018 - 2025) Analysis & Trends

cbdMD has disclosed Shares Outstanding (Diluted Average) across 8 years of filings, most recently posting $4.0 million for Q3 2025.

  • Shares Outstanding (Diluted Average) for Q3 2025 came in at $4.0 million, up 646.22% year-over-year; the trailing twelve-month figure through Sep 2025 was $4.0 million (up 646.22% YoY), and the FY2025 annual result was $4.0 million, up 646.22% from the prior year.
  • Shares Outstanding (Diluted Average) came in at $4.0 million for Q3 2025 at cbdMD, up from $539069.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $61.4 million in Q2 2021 to a low of $539069.0 in Q3 2024.
  • The 5-year median for Shares Outstanding (Diluted Average) is $2.7 million (2023), against an average of $21.8 million.
  • Across the five-year window, Shares Outstanding (Diluted Average) tumbled 97.85% in 2022 and jumped 646.22% in 2025, its largest moves.
  • cbdMD's Shares Outstanding (Diluted Average) stood at $57.8 million in 2021, then climbed by 4.38% to $60.4 million in 2022, then tumbled by 96.65% to $2.0 million in 2023, then sank by 73.34% to $539069.0 in 2024, then surged by 646.22% to $4.0 million in 2025.
  • The last three Shares Outstanding (Diluted Average) figures came in at $4.0 million (Q3 2025), $539069.0 (Q3 2024), and $3.0 million (Q1 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.18 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.40 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 47.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 103.40 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 506.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 cbdMD 3,884.57 -3.38 Mn 3.00 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 4.02 Mn
Sep 30, 2024 539,069.00
Mar 31, 2024 2.96 Mn
Sep 30, 2023 2.02 Mn
Jun 30, 2023 2.38 Mn
Mar 31, 2023 1.35 Mn
Dec 31, 2022 60.36 Mn
Sep 30, 2022 1.33 Mn
Jun 30, 2022 1.32 Mn
Mar 31, 2022 1.31 Mn
Dec 31, 2021 57.83 Mn
Sep 30, 2021 54.94 Mn
Jun 30, 2021 61.43 Mn
Mar 31, 2021 52.79 Mn
Dec 31, 2020 52.13 Mn
Sep 30, 2020 45.17 Mn
Jun 30, 2020 42.53 Mn
Mar 31, 2020 37.34 Mn
Dec 31, 2019 28.55 Mn
Sep 30, 2019 17.89 Mn